Showing results (191-200 of 437) with videos related to
Sort By:
Pageof 44
Pediatric Rheumatology Online Journal|May 4, 2021
Electronic forms for patient reported outcome measures (PROMs) are an effective, time-efficient, and cost-minimizing alternative to paper formsJennifer Y Yu, Talia Goldberg, Nicholas Lao, et al.The Journal of Pediatrics|November 3, 2004
Clinical and cost implications of target joints in Canadian boys with severe hemophilia AMelissa Kern, Victor Blanchette, Ann Marie Stain, et al.The Journal of Rheumatology|August 3, 2016
The Responsiveness of the Modified Childhood Health Assessment QuestionnaireShannon Peters, Sylvia Ota, Emily Bolous, et al.Journal of Clinical Epidemiology|October 8, 2010
Survival distributions impact the power of randomized placebo-phase design and parallel groups randomized clinical trialsLusine Abrahamyan, Chuan Silvia Li, Joseph Beyene, et al.Arthritis and Rheumatism|February 13, 2003
Use of complementary and alternative medicine by pediatric rheumatology patientsLorrie E M Hagen, Rayfel Schneider, Derek Stephens, et al.The Journal of Rheumatology|October 7, 2004
Favorable outcome in patients with renal involvement complicating macrophage activation syndrome in systemic onset juvenile rheumatoid arthritisAthimalaipet V Ramanan, Norman D Rosenblum, Brian M Feldman, et al.The Journal of Rheumatology|December 22, 2006
The Quality of My Life questionnaire: the minimal clinically important difference for pediatric rheumatology patientsGrace W K Gong, Nancy L Young, Helen Dempster, et al.Arthritis Care & Research|August 27, 2010
Cost-effectiveness of biologics in polyarticular-course juvenile idiopathic arthritis patients unresponsive to disease-modifying antirheumatic drugsWendy J Ungar, Vania Costa, Rebecca Hancock-Howard, et al.Rheumatic Diseases Clinics of North America|April 7, 2018
Strategies for Dealing with Missing Accelerometer DataSamantha Stephens, Joseph Beyene, Mark S Tremblay, et al.Journal of General Internal Medicine|July 18, 2014
Using value-of-information methods when the disease is rare and the treatment is expensive--the example of hemophilia ALusine Abrahamyan, Andrew R Willan, Joseph Beyene, et al.Pageof 44